MERIDIAN BIOSCIENCE INC 3 SEC Filings

Filed On	Filing
22 Feb 2022	Form 3: Kitzmiller Andrew S., Executive Vice President & CFO Holds 0 shares of Common Stock
03 Jan 2022	Form 3: Smith Julie Diana, Sr VP, Controller, PAO Holds 25,600 shares of Common Stock
29 Jul 2020	Form 3: Bihl Anthony P Iii, Director Holds 0 shares of Common Stock
29 Jul 2020	Form 3: Bihl Anthony P Iii, Director Holds 0 shares of Common Stock
21 May 2020	Form 3: Serafini-Lamanna Tony, Executive VP-Diagnostics Holds 21,020 shares of Common Stock
07 Jan 2019	Form 3: Baldasare Bryan T, Chief Accounting Officer Holds 30,871 shares of Common Stock
24 Sep 2018	Form 3: Williams Felicia, Director Holds 0 shares of Common Stock
06 Jun 2018	Form 3: Rasmussen Eric S., Executive VP-Bus Dev/Strategy Holds 0 shares of Common Stock
25 Apr 2018	Form 3: Weltzien Lourdes, Executive VP, Life Science Holds 36,685 shares of Common Stock
11 Oct 2017	Form 3: Kenny John P., Director Holds 0 shares of Common Stock
09 Aug 2017	Form 3: Rice John McCune Jr., Director No securities owned
28 Mar 2016	Form 3: Winslow Amy, EVP, Pres & CEO of Magellan No securities owned
18 Aug 2015	Form 3: McIlwraith John, Director Holds 1,000 shares of Common Stock
18 Aug 2015	Form 3: Sazdanoff Catherine, Director No securities owned
24 Jul 2014	Form 3: Ellingwood Dwight E, Director No securities owned
25 Apr 2014	Form 3: Shaughnessy Michael C., EVP, Pres Meridian Global Dx Holds 5,400 shares of Common Stock
29 Apr 2011	Form 3: Elagin Vecheslav A, VP, Research and Development Holds 20,000 shares of Common Stock
29 Apr 2011	Form 3: Johnson Marviette D., VP, Human Resources Holds 19,011 shares of Common Stock
22 Apr 2011	Form 3: Calzavara Marco G., Pres & Managing Director, MBE No securities owned
20 Jul 2009	Form 3: Anderson James M., Director Holds 0 shares of Common Stock

Comments